(In thousands) | Current | Deferred | Total | ||||||
Year ended December 31, 2017: | |||||||||
U.S. federal | $ | 89,154 | $ | 12,190 | $ | 101,344 | |||
State and local | 7,735 | 1,427 | 9,162 | ||||||
Total | $ | 96,889 | $ | 13,617 | $ | 110,506 | |||
Year ended December 31, 2016: | |||||||||
U.S. federal | $ | 116,753 | $ | (2,036 | ) | $ | 114,717 | ||
State and local | 9,457 | (23 | ) | 9,434 | |||||
Total | $ | 126,210 | $ | (2,059 | ) | $ | 124,151 | ||
Year ended December 31, 2015: | |||||||||
U.S. federal | $ | 102,607 | $ | 7,084 | $ | 109,691 | |||
State and local | 6,551 | 348 | 6,899 | ||||||
Total | $ | 109,158 | $ | 7,432 | $ | 116,590 | |||
(In thousands) | 2017 | 2016 | 2015 | ||||||
Unrealized gain (loss) on securities available for sale | $ | 2,104 | $ | (13,952 | ) | $ | (19,634 | ) | |
Accumulated pension (benefit) loss | (184 | ) | 778 | 1,478 | |||||
Compensation expense for tax purposes in excess of amounts recognized for financial reporting purposes | — | (3,390 | ) | (2,132 | ) | ||||
Income tax (benefit) expense allocated to stockholders’ equity | $ | 1,920 | $ | (16,564 | ) | $ | (20,288 | ) | |
(In thousands) | 2017 | 2016 | ||||
Deferred tax assets: | ||||||
Loans, principally due to allowance for loan losses | $ | 40,341 | $ | 61,233 | ||
Equity-based compensation | 8,201 | 12,633 | ||||
Deferred compensation | 5,647 | 7,998 | ||||
Private equity investments | 5,473 | 9,667 | ||||
Accrued expenses | 5,245 | 16,638 | ||||
Unearned fee income | 3,701 | 3,819 | ||||
Other | 4,430 | 6,071 | ||||
Total deferred tax assets | 73,038 | 118,059 | ||||
Deferred tax liabilities: | ||||||
Equipment lease financing | 45,825 | 71,355 | ||||
Unrealized gain on securities available for sale | 13,603 | 18,572 | ||||
Land, buildings and equipment | 8,592 | 10,375 | ||||
Undistributed earnings of subsidiaries | 7,094 | 23 | ||||
Intangibles | 5,732 | 9,105 | ||||
Other | 6,569 | 8,765 | ||||
Total deferred tax liabilities | 87,415 | 118,195 | ||||
Net deferred tax liabilities | $ | (14,377 | ) | $ | (136 | ) |
(In thousands) | 2017 | 2016 | 2015 | ||||||
Computed “expected” tax expense | $ | 150,461 | $ | 139,840 | $ | 133,112 | |||
Increase (decrease) in income taxes resulting from: | |||||||||
Tax-exempt interest, net of cost to carry | (20,295 | ) | (20,033 | ) | (19,083 | ) | |||
Contribution of appreciated securities | (10,864 | ) | — | — | |||||
Tax reform enactment | (6,753 | ) | — | — | |||||
Share-based award payments | (6,613 | ) | — | — | |||||
State and local income taxes, net of federal tax benefit | 5,955 | 6,132 | 4,484 | ||||||
Tax deductible dividends on allocated shares held by the Company’s ESOP | (966 | ) | (1,044 | ) | (1,093 | ) | |||
Other | (419 | ) | (744 | ) | (830 | ) | |||
Total income tax expense | $ | 110,506 | $ | 124,151 | $ | 116,590 | |||
(In thousands) | 2017 | 2016 | ||||
Unrecognized tax benefits at beginning of year | $ | 1,228 | $ | 1,278 | ||
Gross increases – tax positions in prior period | 5 | — | ||||
Gross decreases – tax positions in prior period | — | (1 | ) | |||
Gross increases – current-period tax positions | 268 | 269 | ||||
Lapse of statute of limitations | (293 | ) | (318 | ) | ||
Unrecognized tax benefits at end of year | $ | 1,208 | $ | 1,228 | ||